Dimethyl sulfoxide (DMSO): toxicology, pharmacology, and current clinical usefulness.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000937:Antigen-Antibody Reactions; D001419:Bacteria / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003094:Collagen / Q000378:metabolism; D006224:Cricetinae; D004121:Dimethyl Sulfoxide / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D004231:Diuresis / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D006168:Guinea Pigs; D000882:Haplorhini; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D051379:Mice; D010425:Pentolinium Tartrate / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013514:Surgical Procedures, Operative; D013552:Swine; D014570:Urologic Diseases / Q000188:drug therapy; D014665:Vasodilator Agents / Q000494:pharmacology; D014947:Wounds and Injuries / Q000188:drug therapy
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D002800:Cholinesterase Inhibitors; D006584:Hexamethonium Compounds; D014665:Vasodilator Agents; D003094:Collagen; D010425:Pentolinium Tartrate; D004121:Dimethyl Sulfoxide